Skip to main content
. 2018 Jan 10;29(3):759–774. doi: 10.1681/ASN.2017090958

Table 1.

Causes of FSGS

Primary Circulating podocyte-toxic factor
Secondary: Maladaptive Reduced number of functioning nephrons (e.g., unilateral renal agenesis, renal dysplasia, oligomeganephronia, glycogen storage disease, low birth weight)
Abnormal stress on an initially normal nephron population (e.g., morbid obesity, surgical reduction of renal mass [usually >75%], reflux nephropathy, high-protein diet, sickle cell disease, any advanced kidney disease with substantial loss of nephrons)
Other causes: sleep apnea, cyanotic congenital heart disease, renal artery stenosis, malignant hypertension, cholesterol emboli
Secondary: Viral HIV (established), CMV (probably), parvovirus B19 (possibly), EBV (possibly), HCV (possibly), hemophagocytic syndrome (possibly)
Secondary: Drug induced Direct-acting antiviral therapy (ledipasvir, sofosbuvir), mTOR inhibitors, calcineurin inhibitors, anthracyclines, heroin(adulterants), lithium, IFN, anabolic steroids
Genetic Renal limited (Table 2)
Syndromic (Table 3)
Unknown

CMV, cytomegalovirus; EBV, Epstein-Barr virus; HCV, Hepatitis C virus; mTOR, mammalian target of rapamycin. IFN, interferon